2009-09 to 2014-07 PhD: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
2005-09 to 2009-07 Bachelor's Degree: Shandong University, School of Pharmacy
2020-08 to Present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Researcher
2015-02 to 2020-07 - Johns Hopkins University - Postdoctoral Researcher
AACR-Get Your Rear in Gear Philadelphia Scholar in Training Award (2019): First Prize
Research
Epigenetics and Precision Medicine in Cancer Molecular Mechanisms of Cancer Transcription Abnormalities and Innovative Drug Discovery Target Validation and Innovative Drug Discovery Based on New Mechanisms of Epigenetic Regulation
Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties, Corresponding Author, 2022
A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones, 10th Author, 2021
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction, 16th Author, 2021
Biochemical Studies and Molecular Dynamic Simulations Reveal the Molecular Basis of Conformational Changes in DNA Methyltransferase-1, 2nd Author, 2018
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk, 7th Author, 2018
Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells, 5th Author, 2017
Functional interplay between the RK motif and linker segment dictates Oct4–DNA recognition, 1st Author, 2015
An Arginine-rich Motif of Ring Finger Protein 4 (RNF4) Oversees the Recruitment and Degradation of the Phosphorylated and SUMOylated Kruppel-associated Box Domain-associated Protein 1 (KAP1)/TRIM28 Protein during Genotoxic Stress, 3rd Author, 2014
Catalytic Mechanism of Histone Acetyltransferase p300: From the Proton Transfer to Acetylation Reaction, 3rd Author, 2014
K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5, 10th Author, 2014
Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants, 4th Author, 2014
Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2., 1st Author, 2014
Discovery of two aminoglycoside antibiotics as inhibitors targeting the menin–mixed lineage leukaemia interface, 8th Author, 2014
c-MET kinase inhibitors: a patent review (2011-2013), 2nd Author, 2014
Area of Focus
3D Genomics | Epigenetics | Transcriptional Regulation | Cardiovascular Diseases | Cancer | Human Diseases | Molecular Biology | Cellular Medicine | Genetic Analysis | Disease Mechanisms